Antitumorigenic targets of cannabinoids – current status and implications.

Author(s): Ramer R, Hinz B

Institute of Toxicology and Pharmacology , Rostock University Medical Center , Rostock , Germany

Subject: Cancer View the study


The main goal of targeting endocannabinoid structures for systemic anticancer treatment is the comparatively good safety profile of cannabinoid compounds. In addition, antitumorigenic mechanisms of cannabinoids are not restricted to a single molecular cascade but involve multiple effects on various levels of cancer progression such as angiogenesis and metastasis...

Source: Expert Opinion on Therapeutic Targets (Price: $89)
Share Tweet

More medical studies related to Cancer:

View all medical studies >>

Subscribe for daily cannabis news, announcements, and business insights.

Рекламная полиграфическая продукция читать далее

узнать больше